TransMedics Group, Inc. (TMDX) Revenue History
TransMedics Group, Inc. (TMDX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | $23.60M |
| 2020-12-31 | $25.64M |
| 2021-12-31 | $30.26M |
| 2022-12-31 | $93.46M |
| 2023-12-31 | $241.62M |
| 2024-12-31 | $441.54M |
| 2025-12-31 | $605.49M |
How TMDX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
| AXSM | Axsome Therapeutics Inc. | $638.50M |
| TGTX | TG Therapeutics Inc. | $616.29M |
| AZTA | Azenta Inc. | $593.82M |
| ATRC | AtriCure Inc. | $534.53M |
These are five companies in the same sector as TMDX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TransMedics Group, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TMDX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMDX | $94.77 | +4.31% | 0.63M |
| 3 | ||||
| 4 | ||||
| 5 |